{"id":58574,"date":"2022-11-25T16:13:32","date_gmt":"2022-11-25T07:13:32","guid":{"rendered":"https:\/\/www.pp.u-tokyo.ac.jp\/?p=38370"},"modified":"2022-11-25T16:13:32","modified_gmt":"2022-11-25T07:13:32","slug":"2022-11-25-38370-2","status":"publish","type":"post","link":"https:\/\/graspp.neopa.jp\/en\/events\/2022-11-25-38370-2\/","title":{"rendered":"Health Technology Assessment International Symposium"},"content":{"rendered":"<p><\/p>\n<h2><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.pp.u-tokyo.ac.jp\/wp-content\/uploads\/2022\/11\/HPTAinternational-symposium2212en-1024x576.jpg\" alt=\"\" width=\"1024\" height=\"576\" class=\"aligncenter size-large wp-image-38371\" \/><\/h2>\n<h2>Health Technology Assessment International Symposium<\/h2>\n<h3>Project Report in GraSPP on \u201cHealth Policy &amp; Technology Assessment Research and Training Program 2017 \u2013 2021\u201d<br \/>\nand \u201cInternational Joint Research on COVID-19\u201d<\/h3>\n<p><strong>Date &amp; Time:\u00a0<\/strong>December 21, 2022<br \/>\nPart I 16:30 \u2013 18:40 (JST)<br \/>\nPart II 20:20 \u2013 22:00 (JST)<\/p>\n<p><strong>Venue:<\/strong> Virtual Online Meeting<\/p>\n<p><strong>Organizer:<\/strong> Graduate School of Public Policy (GraSPP), The University of Tokyo<\/p>\n<p><strong>Co-Sponsor:<\/strong> The Canon Institute for Global Studies (CIGS)<\/p>\n<p><strong>Auspice:<\/strong> Musashino Institute for Global Affairs, Musashino University<\/p>\n<p><strong>Please register <a href=\"https:\/\/zoom.us\/webinar\/register\/WN_myfyQfBZQCCtTecwoMGBPA\">here<\/a>\u00a0\u00a0<\/strong><\/p>\n<h4 align=\"center\" style=\"text-align: left;\"><b><span lang=\"EN-US\">Program<\/span><\/b><\/h4>\n<h5 align=\"center\" style=\"text-align: left;\"><b><span lang=\"EN-US\">Part I\u00a0<\/span><\/b><span lang=\"EN-US\">\u201cProject Report on Health Policy &amp; Technology Assessment Research\u00a0<\/span><span lang=\"EN-US\">and Training Program 2017-2021\u201d<b><\/b><\/span><\/h5>\n<p>The research and education project on health policy and technology assessment (HPTA) was initiated in April 2017 in the Graduate School of Public Policy (GraSPP), University of Tokyo. The HPTA was designed to collaborate with the MHLW officers and the affiliated experts who have responsibility for a new policy of health technology assessment (HTA), which was provisionally introduced in 2016 and institutionalized in 2019. The first part of this symposium reports the achievement of the HPTA project reviewing the past six years from 2017 to 2022 and seeks future directions for Japan, learning global challenges from an European expert of HTA.<\/p>\n<p align=\"center\" style=\"text-align: left;\"><span lang=\"EN-US\">16:30-16:40\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>Opening Remarks<\/strong><\/span><strong>\u3000<\/strong><\/p>\n<p align=\"center\" style=\"text-align: left; padding-left: 120px;\"><span lang=\"EN-US\">Hideaki Shiroyama<\/span><span lang=\"EN-US\">, <\/span><span lang=\"EN-US\">Professor, Graduate School of Public Policy,\u00a0<\/span><span lang=\"EN-US\">The University of Tokyo<\/span><span lang=\"ZH-TW\">\u3000<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">16:40-16:50<\/span><span lang=\"EN-US\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><strong><span lang=\"EN-US\">Co-Sponsor\u2019s Remarks<\/span><\/strong><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Toshihiko Fukui, President, The Canon Institute for Global Studies<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">16:50-17:15\u00a0 \u00a0 \u00a0 \u00a0 &#8220;<strong>Report on Health Policy &amp; Technology Assessment Research and Training Program 2017 \u2013 2021<i>&#8220;<\/i><\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Isao Kamae, Project Professor, <\/span><span lang=\"EN-US\">GraSPP, The University of Tokyo<\/span><span lang=\"EN-US\"><\/span><span lang=\"EN-US\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">17:15-17:30\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>&#8220;Public-private partnership on HTA education in GraSPP 2017\u20132021&#8221;<\/strong><\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Makoto Kobayashi Director and Chief Operating Officer, Crecon Medical Assessment, Japan<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">17:30-18:30\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong><i>&#8220;<\/i>Global Challenges of HTA in Comparison with Germany, France and Japan<i>&#8220;<\/i><\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">J\u00f6rg Mahlich, Market Access &amp; Government Affairs Lead, Miltenyi Biomedicine, and Research Affiliate, D\u00fcsseldorf Institute for Competition Economics (DICE) Germany<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">18:30-18:40\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>Dean\u2019s Remarks<\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Keisuke Iida, <\/span><span lang=\"EN-US\">Dean, GraSPP, The University of Tokyo<\/span><\/p>\n<p>18:40-20:20\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Intermission<\/p>\n<h5 align=\"center\" style=\"text-align: left;\"><b><span lang=\"EN-US\">Part II\u00a0<\/span><\/b><span lang=\"EN-US\">\u201cProject Report on <\/span><span lang=\"EN-US\">International Joint Research on COVID-19<\/span><span lang=\"EN-US\">\u201d<b><\/b><\/span><\/h5>\n<p><span lang=\"EN-US\">The objectives of this session are to introduce the International Joint Study on Public Health Economics of the COVID-19 Pandemic with the research grant, \u201cHitachi Fund Support for Research Related to Infectious Diseases,\u201d which was initiated on the platform of GraSPP, the University of Tokyo in December 2021. Three groups with international experts in health economics and outcomes research in Europe, Asia, and North-America discuss the gap between myth and truth experienced during the pandemic so far, and share the lessons learned, focusing on public health economics, testing strategies, and simulation impact of vaccinations.<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">20:20-20:25\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>Primary Investigator\u2019s Remarks<\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Akio Onishi, Visiting Professor, GraSPP, The University of Tokyo<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">20:25-20:55\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>Asia Group progress report: &#8220;Evidence-based testing strategies&#8221;<\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\">Isao Kamae, Project Professor, GraSPP, The University of Tokyo<br \/>\n<span lang=\"EN-US\">Makoto Kobayashi, Director and Chief Operating Officer, Crecon Medical Assessment, Japan<br \/>\nRyo Watanabe, Associate Professor, Kanagawa University of Human Services, Japan<br \/>\nChee Jen Chang, Distinguished Professor, Chang Gung University, Taiwan<br \/>\nHwee-Lin Wee, Associate Professor, National University of Singapore<br \/>\n<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">20:55-21:25\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>Europe Group progress report:\u00a0&#8220;Public health economics&#8221;<\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Ulf Persson, Senior adviser and Professor, Swedish Institute for Health Economics, Sweden et al.<br \/>\nPierre-Y Geoffard, Professor, Paris School of Economics, France<br \/>\nJ\u00f6rgen M\u00f6ller, Vice President, Evidera, Sweden<br \/>\n<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">21:25-21:55\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>North America group\u00a0progress report &#8220;Simulation and the forecast impact of vaccination&#8221;<\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Jaime Caro, Chief Scientist, Evidera, Professor, McGill University, Canada, and Professor in Practice at London School of Economics, UK<br \/>\nDebra Schaumberg, Professor of Ophthalmology and Visual Sciences, University of Utah, USA<br \/>\nJack Ishak, Vice President, Evidera, Canada<\/span><\/p>\n<p align=\"left\"><span lang=\"EN-US\">21:55-22:00\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>Closing Remarks<\/strong><\/span><\/p>\n<p align=\"left\" style=\"padding-left: 120px;\"><span lang=\"EN-US\">Isao Kamae, Project Professor, GraSPP, The University of Tokyo<\/span><\/p>\n<p align=\"left\">22:00\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>Adjournment\u00a0<\/strong><\/p>\n<p align=\"left\"><span lang=\"EN-US\"><\/span><\/p>\n<h4 align=\"left\"><span lang=\"EN-US\">Speakers (In order of appearance)<\/span><span lang=\"EN-US\"><\/span><\/h4>\n<div><iframe loading=\"lazy\" class=\"embed-pdf-viewer\" src=\"https:\/\/www.pp.u-tokyo.ac.jp\/wp-content\/uploads\/2022\/11\/HPTA-profile-Part-l.pdf\" height=\"750\" width=\"100%\" title=\"HPTA Profile Part L\"><\/iframe><\/p>\n<p><a href=\"https:\/\/www.pp.u-tokyo.ac.jp\/wp-content\/uploads\/2022\/11\/HPTA-profile-Part-l.pdf\" title=\"HPTA Profile Part L\">HPTA Profile Part L<\/a><\/p>\n<\/div>\n<p>https:\/\/www.pp.u-tokyo.ac.jp\/wp-content\/uploads\/2022\/11\/HPTA-Profile-Part-ll-.pdf<\/p>","protected":false},"excerpt":{"rendered":"<p>Health Technology Assessment International Symposium Project Report in GraSPP on \u201cHealth Policy &amp; Technolo [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[319],"coauthors":[234],"class_list":["post-58574","post","type-post","status-publish","format-standard","hentry","category-events","tag-hpta"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/posts\/58574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/comments?post=58574"}],"version-history":[{"count":0,"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/posts\/58574\/revisions"}],"wp:attachment":[{"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/media?parent=58574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/categories?post=58574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/tags?post=58574"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/graspp.neopa.jp\/en\/wp-json\/wp\/v2\/coauthors?post=58574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}